PART I. FINANCIAL INFORMATION
|
|
|
|
|
|
|
ITEM 1.
|
Financial Statements
|
3
|
|
|
|
|
|
|
Condensed balance sheets as of June 30, 2017 (unaudited) and December 31, 2016
|
4
|
|
|
|
|
|
|
Condensed statements of operations for the three and six months ended June 30, 2017 and 2016 (unaudited)
|
5
|
|
|
|
|
|
|
Condensed statement of stockholders’ deficit for the six months ended June 30, 2017 (unaudited)
|
6
|
|
|
|
|
|
|
Condensed statements of cash flows for the six months ended June 30, 2017 and 2016 (unaudited)
|
7
|
|
|
|
|
|
|
Notes to condensed financial statements (unaudited)
|
8
|
|
|
|
|
|
ITEM 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
12
|
|
ITEM 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
15
|
|
ITEM 4.
|
Controls and Procedures
|
15
|
|
|
|
|
PART II. OTHER INFORMATION
|
|
|
|
|
|
|
ITEM 1.
|
Legal Proceedings
|
16
|
|
ITEM 1A.
|
Risk Factors
|
16
|
|
ITEM 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
16
|
|
ITEM 3.
|
Defaults Upon Senior Securities
|
16
|
|
ITEM 4.
|
Mine Safety Disclosures
|
16
|
|
ITEM 5.
|
Other Information
|
16
|
|
ITEM 6.
|
Exhibits
|
17
|
|
|
|
|
|
SIGNATURES
|
18
|
PART I — FINANCIAL INFORMATION
Item 1. Interim Condensed Financial Statements and Notes to Interim Financial Statements
General
The accompanying reviewed condensed interim financial unaudited statements have been prepared in accordance with the instructions to Form 10-Q. Therefore, they do not include all information and footnotes necessary for a complete presentation of financial position, results of operations, cash flows, and stockholders’ deficit in conformity with generally accepted accounting principles. Except as disclosed herein, there has been no material change in the information disclosed in the notes to the financial statements included in the Company’s annual report on Form 10-K for the year ended December 31, 2016. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature. Operating results for the three and six months ended June 30, 2017 are not necessarily indicative of the results that can be expected for the year ending December 31, 2017.
EIGHT DRAGONS COMPANY
Condensed Balance Sheets
|
|
June 30
|
|
|
December 31
|
|
|
|
2017
|
|
|
2016
|
|
|
|
(Unaudited)
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT ASSETS
|
|
|
|
|
|
|
Cash on hand and in bank
|
|
$
|
17,327
|
|
|
$
|
-
|
|
Accounts receivable
|
|
|
7,284
|
|
|
|
-
|
|
Total Current Assets
|
|
|
24,611
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Loan Receivable
|
|
|
17,000
|
|
|
|
-
|
|
Deposit receivable
|
|
|
22,000
|
|
|
|
-
|
|
Investment in Protect Pharmaceutical Corporation (Note 4)
|
|
|
3,840,000
|
|
|
|
-
|
|
Intangible assets
|
|
|
102,400
|
|
|
|
-
|
|
Receivable from affiliate
|
|
|
345,000
|
|
|
|
-
|
|
Investment in Rock3r Labs, LLC (Note 4)
|
|
|
13,386,826
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
17,737,837
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES
|
|
|
|
|
|
|
|
|
Accrued expenses
|
|
$
|
5,301
|
|
|
$
|
7,875
|
|
Note payable to Firstfire Global Opportunities Fund, LLC
|
|
|
305,000
|
|
|
|
-
|
|
Notes payable to controlling stockholder
|
|
|
-
|
|
|
|
1,025,027
|
|
Accrued interest payable to controlling stockholder
|
|
|
-
|
|
|
|
832,800
|
|
Total current liabilities
|
|
|
310,301
|
|
|
|
1,865,702
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHAREHOLDERS' DEFICIT
|
|
|
|
|
|
|
|
|
Preferred stock series A - $0.0001 par value. 50,000,000 shares authorized; 1,000,000 and none issued and outstanding, respectively
|
|
|
37,500
|
|
|
|
-
|
|
Common stock - $0.0001 par value. 100,000,000 shares authorized. 40,953,594 and 362,200 shares issued and outstanding, respectively
|
|
|
4,095
|
|
|
|
36
|
|
Additional paid in capital
|
|
|
83,425,625
|
|
|
|
31,690,302
|
|
Accumulated deficit
|
|
|
(66,039,684
|
)
|
|
|
(33,556,040
|
)
|
Total shareholders' equity (deficit)
|
|
|
17,427,536
|
|
|
|
(1,865,702
|
)
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders' equity (deficit)
|
|
$
|
17,737,837
|
|
|
$
|
-
|
|
The accompanying notes are an integral part of these condensed financial statements.
EIGHT DRAGONS COMPANY
Condensed Statements of Operations and Comprehensive Loss
For the Three and Six Months Ended June 30, 2017 and 2016
(Unaudited)
|
|
Three months ended
June 30,
|
|
|
Six months ended
June 30,
|
|
|
|
2017
|
|
|
2016
|
|
|
2017
|
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
7,284
|
|
|
$
|
-
|
|
|
$
|
7,284
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative expenses
|
|
|
34,348,790
|
|
|
|
9,358
|
|
|
|
34,356,360
|
|
|
|
31,404
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(34,341,506
|
)
|
|
|
(9,358
|
)
|
|
|
(34,349,076
|
)
|
|
|
(31,404
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Income (Expense)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on extinguishment of debt (Note 6)
|
|
|
-
|
|
|
|
-
|
|
|
|
1,889,938
|
|
|
|
-
|
|
Interest expense
|
|
|
(5,000
|
)
|
|
|
(26,369
|
)
|
|
|
(24,506
|
)
|
|
|
(49,874
|
)
|
Total other Expense
|
|
|
(5,000
|
)
|
|
|
(26,369
|
)
|
|
|
1,865,432
|
|
|
|
(49,874
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before provision for income taxes
|
|
|
(34,346,506
|
)
|
|
|
(35,727
|
)
|
|
|
(32,483,644
|
)
|
|
|
(81,278
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss
|
|
|
(34,346,506
|
)
|
|
|
(35,727
|
)
|
|
|
(32,483,644
|
)
|
|
|
(81,278
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Comprehensive Income
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive Loss
|
|
$
|
(34,346,506
|
)
|
|
$
|
(35,727
|
)
|
|
$
|
(32,483,644
|
)
|
|
$
|
(81,278
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss per share of common stock outstanding computed on net loss -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
basic and fully diluted
|
|
$
|
(1.52
|
)
|
|
$
|
(0.10
|
)
|
|
$
|
(2.87
|
)
|
|
$
|
(0.22
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number of shares outstanding –
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
basic and fully diluted
|
|
|
22,625,390
|
|
|
|
362,200
|
|
|
|
11,309,293
|
|
|
|
362,200
|
|
The accompanying notes are an integral part of these condensed financial statements.
EIGHT DRAGONS COMPANY
Statement Of Changes in Shareholders' Deficits
For the Six Months Ended June 30, 2017
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
|
|
|
|
|
|
|
Series A Preferred Stock
|
|
|
Common Stock
|
|
paid-in
|
|
|
Accumulated
|
|
|
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
capital |
|
|
deficit |
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at December 31, 2016
|
|
|
-
|
|
|
$
|
-
|
|
|
|
362,200
|
|
|
$
|
36
|
|
|
$
|
31,690,302
|
|
|
$
|
(33,556,040
|
)
|
|
$
|
(1,865,702
|
)
|
Stock issued in exchange for consulting and professional services
|
|
|
1,000,000
|
|
|
|
37,500
|
|
|
|
26,228,403
|
|
|
|
2,623
|
|
|
|
33,569,734
|
|
|
|
|
|
|
|
33,609,857
|
|
Stock issued to purchase investment in Rock3r Labs, LLC
|
|
|
-
|
|
|
|
-
|
|
|
|
9,677,208
|
|
|
|
968
|
|
|
|
12,385,858
|
|
|
|
|
|
|
|
12,386,826
|
|
Stock issued to convertible debt holders
|
|
|
-
|
|
|
|
-
|
|
|
|
1,355,783
|
|
|
|
136
|
|
|
|
1,517,664
|
|
|
|
|
|
|
|
1,517,800
|
|
Stock issued for debt financing from First Fire Solutions
|
|
|
-
|
|
|
|
-
|
|
|
|
250,000
|
|
|
|
25
|
|
|
|
319,975
|
|
|
|
|
|
|
|
320,000
|
|
Stock issued for purchase of Protect Pharmaceutical Solutions
|
|
|
-
|
|
|
|
-
|
|
|
|
3,000,000
|
|
|
|
300
|
|
|
|
3,839,700
|
|
|
|
|
|
|
|
3,840,000
|
|
Stock issued for purchase of Park Road Solutions
|
|
|
-
|
|
|
|
-
|
|
|
|
80,000
|
|
|
|
8
|
|
|
|
102,392
|
|
|
|
|
|
|
|
102,400
|
|
Net loss
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(32,483,644
|
)
|
|
|
(32,483,644
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at June 30, 2017
|
|
|
1,000,000
|
|
|
$
|
37,500
|
|
|
|
40,953,594
|
|
|
$
|
4,095
|
|
|
$
|
83,425,625
|
|
|
$
|
(66,039,684
|
)
|
|
$
|
17,427,536
|
|
The accompanying notes are an integral part of these condensed financial statements.
EIGHT DRAGONS COMPANY
Condensed Statements of Cash Flows
For the Three and Six Months Ended June 30, 2017 and 2016
(Unaudited)
|
|
Six months ended
|
|
|
|
June 30,
|
|
|
|
2016
|
|
|
2016
|
|
Cash Flows from Operating Activities
|
|
|
|
|
|
|
Net loss
|
|
$
|
(32,483,644
|
)
|
|
$
|
(81,278
|
)
|
Adjustments to reconcile net loss to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
Gain on the extinguishment of debt
|
|
|
(1,889,938
|
)
|
|
|
- |
|
Preferred stock issued for consulting services
|
|
|
37,500
|
|
|
|
- |
|
Common stock issued for professional and consulting services
|
|
|
33,572,356
|
|
|
|
- |
|
Increase (Decrease) in
|
|
|
|
|
|
|
|
|
Accounts receivable
|
|
|
(7,284
|
)
|
|
|
-
|
|
Receivable from affiliate
|
|
|
(345,000
|
)
|
|
|
-
|
|
Deposit receivable
|
|
|
(22,000 |
) |
|
|
- |
|
(Increase) Decrease in
|
|
|
|
|
|
|
|
|
Accounts payable - trade
|
|
|
-
|
|
|
|
-
|
|
Accrued expense
|
|
|
(2,574
|
)
|
|
|
(13,810
|
)
|
Accrued interest payable - controlling stockholder
|
|
|
32,111
|
|
|
|
49,874
|
|
Net cash used in operating activities
|
|
|
(1,108,473
|
)
|
|
|
(45,214
|
)
|
|
|
|
|
|
|
|
|
|
Cash Flows from Investing Activities
|
|
|
|
|
|
|
|
|
Investment in Rock3r Labs, LLC
|
|
|
(1,000,000
|
)
|
|
|
-
|
|
Net cash used in investing activities
|
|
|
(1,000,000
|
)
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Financing Activities
|
|
|
|
|
|
|
|
|
Proceeds from loan from - controlling stockholder
|
|
|
-
|
|
|
|
45,214
|
|
Loan Receivable
|
|
|
(17,000
|
)
|
|
|
-
|
|
Note payable to Firstfire Global Opportunities Fund, LLC
|
|
|
305,000
|
|
|
|
-
|
|
Stock issued to convertible debt holders
|
|
|
1,517,800
|
|
|
|
-
|
|
Stock issued for debt financing from First Fire
|
|
|
320,000
|
|
|
|
-
|
|
Net cash provided by financing activities
|
|
|
2,125,800
|
|
|
|
45,214
|
|
|
|
|
|
|
|
|
|
|
Increase in Cash
|
|
|
17,327
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Cash at beginning of period
|
|
|
-
|
|
|
|
-
|
|
Cash at end of period
|
|
$
|
17,327
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
Supplemental schedule of non-cash investing and financing activities
|
|
|
|
|
|
|
|
|
Stock issued for acquisition of Park Road Solutions
|
|
|
102,400
|
|
|
|
-
|
|
Stock issued for purchase of interest in Protect Pharmaceutical
|
|
|
3,840,000
|
|
|
|
-
|
|
Stock issued to purchase interest in Rock3r Labs, LLC
|
|
|
12,386,826
|
|
|
|
-
|
|
|
|
$
|
16,329,226
|
|
|
$
|
-
|
|
Supplemental Disclosure of Interest and Income Taxes Paid
|
|
|
|
|
|
|
|
|
Interest paid
|
|
$
|
-
|
|
|
$
|
-
|
|
Income taxes paid
|
|
$
|
-
|
|
|
$
|
-
|
|
The accompanying notes are an integral part of these condensed financial statements.
.
NOTE 1 - CONDENSED FINANCIAL STATEMENTS
The accompanying financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows at June 30, 2017 and for all periods presented herein, have been made.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company's December 31, 2016 audited financial statements. The results of operations for the period ended June 30, 2017 are not necessarily indicative of the operating results for the year ended December 31, 2017.
NOTE 2 - GOING CONCERN
The Company’s financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company does not have significant cash or other material assets, nor does it have an established source of revenues sufficient to cover its operating costs and to allow it to continue as a going concern. It is the intent of the Company to seek a merger with an existing, operating company. In the interim, shareholders of the Company have committed to meeting its minimal operating expenses
NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES
Use of Estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Basic (Loss) per Common Share
Basic loss per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There are no such common stock equivalents outstanding as of June 30, 2017 and 2016.
Recent Accounting Pronouncements
Management has considered all other recent accounting pronouncements issued since the last audit of the Company’s financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements.
NOTE 4 – STOCKHOLDERS’ EQUITY/RELATED-PARTY TRANSACTIONS
On March 13, 2017, a related party controlled by the Chief Executive Officer of the Company completed a private financing transaction with certain private investors (the “Purchasers”), pursuant to a subscription agreement (the “Agreement”) for an aggregate purchase price of One Million, Five Hundred and Seventeen Thousand, Eight Hundred Dollars ($1,517,800) for the benefit of to be named public entity, now Eight Dragons. Subsequently, effective April 28, 2017, the Company assumed all the convertible debentures arising from this private placement in return for a related party making payments for the benefit of, and at the direction of, the Company in the amount of $1,396,371.12. Upon the assumption of the convertible debentures, all convertible debentures were converted into 1,355,783 shares of the Company’s common stock. The related party retains an obligation to wire the remaining $121,429 to the Company and thus holds the funds for the benefit of the Company.
On April 12, 2017, the Company issued One Million (1,000,000) shares of Series A Preferred Stock to the Company’s current control shareholder in consideration for services rendered.
On April 28, 2017, as consideration for services, for contractual obligations, or the conversion of convertible debentures, an aggregate of 37,261,394 shares of the Company’s common stock were issued (including 9,710,295 to our Chief Executive Officer, Una Taylor and 9,677,208 shares to Rokk3r Labs, LLC, in conjunction with the transaction of April 30, 2017 described below, in exchange for 287,067.45 membership units increasing the Company’s minority, non-consolidating investment interest in Rokk3r Labs, LLC to 18.72%) to individuals and entities.
On April 30, 2017, Eight Dragon purchased a minority non-consolidating interest in Rokk3r Labs, LLC., specifically an aggregate of 18.72% of the Member Interests of Rokk3r Labs, LLC. for a purchase price of $1,000,000 (provided at the direction of an entity controlled by Una Taylor for the benefit of the Company) and the issuance of 9,677,208 shares of Company common stock.
On June 30, 2017, as consideration for shares of Protect Pharmaceutical Corporation, 3,000,000 shares of Company common stock were issued to Protect Pharmaceutical Corporation.
The offer and sale of the securities above were effected in reliance on the exemptions for sales of securities not involving a public offering, as set forth in Rule 506 promulgated under the Securities Act of 1933, as amended (the “Securities Act”) and in Section 4(2) and Section 4(6) of the Securities Act and/or Rule 506 of Regulation D.
NOTE 5 – ORGANIZATION AND DESCRIPTION OF BUSINESS
Eight Dragons Company (the “Company”), formerly known as Tahoe Pacific Corporation, Pacific Holdings, Inc. and Ameri-First Financial Group, respectively, is a for profit corporation established under the corporation laws in the State of Nevada. Its predecessor was incorporated in Delaware on September 27, 1996.
On October 24, 2007, the Company changed its state of incorporation from Delaware to Nevada by means of a merger with and into Eight Dragons Company, a Nevada corporation formed on September 26, 2007 solely for the purpose of effecting the reincorporation. The merger was consummated through an exchange of 100 shares in the Nevada Corporation for each share then issued and outstanding in the Delaware Corporation. The Articles of Incorporation and Bylaws of the Nevada Corporation are the Articles of Incorporation and Bylaws of the surviving corporation. Such Articles of Incorporation modified the Company’s capital structure to allow for the issuance of up to 100,000,000 shares of $0.0001 par value common stock and up to 50,000,000 shares of $0.0001 par value preferred stock.
For periods prior to 2000, the Company participated in numerous unsuccessful ventures and corporate name changes, as discussed in greater detail in previous filings with the U. S. Securities and Exchange Commission. Since 2000, the Company has had no operations, significant assets or liabilities.
The Company’s current business plan is to locate and combine with an existing, privately-held company which is profitable or, in management's view, has growth potential, irrespective of the industry in which it is engaged. A combination may be structured as a merger, consolidation, exchange of the Company's common stock for stock or assets or any other form which will result in the Company being the surviving entity.
On June 1, 2017, the Company, through an Agreement and Plan of Merger and Reorganization, acquired all the equity of Park Road Solutions, Inc. (previously Park Road Solutions, LLC), for a purchase price of Eighty Thousand (80,000) shares of the Company common stock. Park Road Solutions, Inc. is an information systems consulting company.
On June 30, 2017, as consideration for 6,100,000 shares of Protect Pharmaceutical Corporation (“PPC”), 3,000,000 shares of our common stock were issued to PPC. This investment was made to establish a strategic partnership which is intended to provide financial exits for portfolio companies of the Company.
NOTE 6 – CHANGE OF CONTROL
As reported on Schedule 14f, filed with the Securities and Exchange Commission on September 9, 2016, effective March 20, 2017, DMJ Acquisitions LLC, the principal stockholder of the Company (“DMJ”), entered into a Stock Purchase Agreement (the “Agreement”) dated January 26, 2017, with Una Taylor through Eight Dragons Acquisitions, LLC, an entity she controls (the “Buyer”), pursuant to which, among other things, DMJ agreed to sell to the Buyer, and the Buyer agreed to purchase from DMJ, a total of 290,500 shares of Common Stock owned of record and beneficially by DMJ (the “Purchased Shares”). The Purchased Shares represented, at closing, approximately 80.2% of the Company’s issued and outstanding shares of Common Stock. The funds for the acquisition were provided by related party controlled by the Chief Executive Officer of the Company and used for the benefit of Eight Dragons Acquisitions, LLC, an entity Una Taylor, our Chief Executive Officer, controls. In connection with the transactions contemplated by the Agreement, the liabilities of Eight Dragons were forgiven and the Board of Directors appointed Una Taylor and Theodore Faison to fill vacancies on the Company’s Board of Directors, and the prior director resigned. The forgiven stockholder liabilities totaled $1,889,939, including $1,037,632 in principle and $852,406 in accrued interest.
NOTE 7 – PROMISSORY NOTE
On April 27, 2017, the Company entered into Securities Purchase Agreements with Firstfire Global Opportunities Fund, LLC (“Firstfire”) for the sale of a convertible promissory note in aggregate principal amount of $330,000 (the “Firstfire Note”). The Firstfire Note bears interest of 1% per annum and provides that the Company issue Firstfire 250,000 shares of common stock as additional consideration for the purchase of the Firstfire Note. The Firstfire note matures on October 27, 2017. The Firstfire Note is convertible into common stock, at the Firstfire’s option, at 75% multiplied by the lowest traded price of the Company common during the ten consecutive trading day period immediately preceding the trading day that the Company receives the Notice of Conversion from the Firstfire. The Firstfire Note has limited piggy back registration rights and prepayment provisions attached.
NOTE 8 – AMENDMENT TO ARTICLES OF INCORPORATION
Effective on April 12, 2017, in conjunction with the filing of the amendment to the Company's Articles of Incorporation with the Nevada Secretary of State, specifically a Certificate of Designation, the Company amended its Articles of Incorporation to designate 1,000,000 shares of its authorized preferred stock as Series A Preferred Stock with specific rights and preferences including the provision that each share of the Series A Preferred Stock shall have one thousand votes on all matters presented to be voted by the holders of Common Stock. The Series A Preferred Stock is not convertible to Common Stock. On April 12, 2017, the Company issued One Million (1,000,000) shares of Series A Preferred Stock to our current control shareholder in consideration for services rendered.
NOTE 9 – 2017 OMNIBUS EQUITY COMPENSATION PLAN
On April 12, 2017, the Board of Directors adopted a Financial Code of Ethics and adopted the 2017 Omnibus Equity Compensation Plan and reserved Five Million (5,000,000) shares of common stock for future issuance under the 2017 Omnibus Equity Compensation Plan. No issuances have been made pursuant to the 2017 Omnibus Equity Compensation Plan to date.
NOTE 10 – SUBSEQUENT EVENTS
In accordance with ASC 855-10, Company management reviewed all material events through the date of this report and determined that there are no additional material subsequent events to report except as noted herein.
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The Following information should be read in conjunction with the consolidated financial statements and notes thereto appearing elsewhere in this Form 10-Q.
Forward-Looking and Cautionary Statements
Unless otherwise indicated, references in this Quarterly Report on Form 10-Q to “we,” “us,” and “our” are to the Company, unless the context requires otherwise. The following discussion and analysis by our management of our financial condition and results of operations should be read in conjunction with our unaudited condensed interim financial statements and the accompanying related notes included in this quarterly report and our audited financial statements and related notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2016 filed with the Securities and Exchange Commission.
Cautionary Statement Regarding Forward-Looking Statements
This report may contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, and we intend that such forward-looking statements be subject to the safe harbors created thereby. These forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. Any such forward-looking statements would be contained principally in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors.” Forward-looking statements include information concerning our possible or assumed future results of operations, business strategies, financing plans, competitive position, industry environment, potential growth opportunities and the effects of regulation. Forward-looking statements include all statements that are not historical facts and can be identified by terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “hopes,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” “would” or similar expressions.
This report may contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, and we intend that such forward-looking statements be subject to the safe harbors created thereby. These forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. Any such forward-looking statements would be contained principally in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors.” Forward-looking statements include information concerning our possible or assumed future results of operations, business strategies, financing plans, competitive position, industry environment, potential growth opportunities and the effects of regulation. Forward-looking statements include all statements that are not historical facts and can be identified by terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “hopes,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” “would” or similar expressions.
Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. We discuss many of these risks in greater detail in “Risk Factors.” Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date of this report. You should read this report and the documents that we reference in this report and have filed as exhibits to the report completely and with the understanding that our actual future results may be materially different from what we expect. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Additional information concerning these and other risks and uncertainties is contained in our filings with the Securities and Exchange Commission, including the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2016.
Unless otherwise indicated or the context otherwise requires, all references in this Form 10-Q to “we,” “us,” “our,” “our company,” “Eight Dragons” refer to Eight Dragons Company.
Our Ability to Continue as a Going Concern
Our independent registered public accounting firm has issued its report dated March 15, 2017, in connection with the audit of our annual financial statements as of December 31, 2016, that included an explanatory paragraph describing the existence of conditions that raise substantial doubt about our ability to continue as a going concern and Note 2 to the unaudited financial statements for the period ended June 30, 2017 also describes the existence of conditions that raise substantial doubt about our ability to continue as a going concern.
Our Business
Eight Dragons Company (OTCQB: EDRG) is a technology-investment company that invests in and operates companies to support a full-stack development eco-system. Headquartered in Miami, Florida and commencing operations in 2017, we seek to help companies using innovation and vision to address the world’s biggest challenges and realize exponential opportunities. For more information on Eight Dragons, please visit our website at www.edrg.com, or follow us on Twitter at @edrgco (both of which are expressly not incorporated into this filing).
Park Road, Inc.
Park Road Solutions, a Miami based company, specializes in outsourced Chief Technology Officer, Chief Security Officer, and information technology managed services. Their experience spans all major verticals including retail, education, finance, and healthcare with core competency and focus on Financial Service Providers such as Hedge Funds and Broker Dealer clients. Park Road Solutions provides unique domain expertise in Financial Regulatory, Compliance, Product Development and Managed IT Services. By utilizing bespoke and turnkey methodologies within its product offering, they ensure every solution is right sized and designed around client needs.
In the second quarter of 2017, we completed a purchase of 18.72% ownership stake in Rokk3r Labs LLC. Specifically, on April 30, 2017, we purchased a minority non-consolidating interest in Rokk3r Labs, LLC., specifically an aggregate of 18.72% of the Member Interests of Rokk3r Labs, LLC. for a purchase price of $1,000,000 (provided at the direction of an entity controlled by Una Taylor for the benefit of our company) and the issuance of 9,677,208 shares of our common stock. Rokk3r Labs is a venture builder and the world’s first ‘co-building’ platform for entrepreneurs, corporations and investors to create exponential startups. Our management believes that Rokk3r Labs increases value, mitigates risk and helps to remain at the edge of innovation. With a focus on leveraging exponential technologies (e.g., the blockchain, artificial intelligence, and Internet of Things) and implementing new-age methods of raising capital, Rokk3r Labs, we believe, is harnessing the global collective genius to co-build companies that change the world. Currently, we are informed that Rokk3r Labs’ portfolio includes over 40 companies.
We will continue to explore other merger or acquisition targets throughout fiscal 2017, although no assurances can be provided that we will complete such acquisitions or that such acquisitions will be profitable.
Because we currently have limited cash, it may be necessary for officers, directors or stockholders to advance funds and we will most likely accrue expenses until additional funding can be accomplished. Management intends to hold expenses to a minimum and to obtain services on a contingency basis when possible. Further, we expect directors to defer any compensation until such time as we have sufficient funds. We have not yet entered into any arrangements or definitive agreements to use outside advisors or consultants or to raise any capital.
We are currently exploring possible funding sources, but we have not entered into any arrangements or agreements for funding as of this time. If we are unable to raise the necessary funding, our expansion plans will be delayed indefinitely. There can be no assurance that we will be able to raise the funds necessary to carry out our business plan on terms favorable to our company, or at all.
Results of Operations
Three Months Ended June 30, 2017, Compared to Three Months Ended June 30, 2016.
Revenues totaled $7,284 for the three months ended June 30, 2017, compared to $-0- for the three months ended June 30, 2016, derived from the business acquired June 1, 2017, Park Road Solutions.
General and administrative expenses (“SG&A”) totaled $34,348,790 for the three months ended June 30, 2017, compared to $9,358 for the three months ended June 30, 2016. SG&A costs in 2017 include the professional and consulting fees, accrued salary of our officers, and rent. A significant portion of the SG&A is a result of the payment of stock and its valuation based on the market price.
Interest expense was $5,000 for the three months ended June 30, 2017, compared to $26,369 for the three months ended June 30, 2016. Interest expense includes accrued and unpaid interest on our debt with principal balances totaling approximately $305,000 at June 30, 2017.
Six Months Ended June 30, 2017, Compared to Six Months Ended June 30, 2016.
Revenues totaled $7,284 for the three months ended June 30, 2017, compared to nil for the three months ended June 30, 2016, derived from the business acquired June 1, 2017, Park Road Solutions.
General and administrative expenses (“SG&A”) totaled $34,356,360 for the six months ended June 30, 2017, compared to $31,404 for the six months ended June 30, 2016. SG&A costs in 2017 include the professional and consulting fees, accrued salary of our officers, and rent. A significant portion of the SG&A is a result of the payment of stock and its valuation based on the market price.
Interest expense was $24,506 for the six months ended June 30, 2017, compared to $49,874 for the six months ended June 30, 2016. Interest expense includes accrued and unpaid interest on our debt with principal balances totaling approximately $305,000 at June 30, 2017.
LIQUIDITY AND CAPITAL RESOURCES
Total assets at June 30, 2017 were $17,737,837, compared with $-0- at December 31, 2016. There was $17,327 in cash, compared to $-0- at December 31, 2016.
Total liabilities at June 30, 2017 were $310,301, consisting of $5,301 in accrued expenses, and $305,000 in a note payable. At December 31, 2016, total liabilities were $1,865,702.
Because we currently have limited revenues and limited available cash, for the immediate future we believe we will have to rely on potential advances from stockholders to continue to implement our business activities. There is no assurance that our stockholders will continue indefinitely to provide additional funds or pay our expenses. It is likely the only other source of funding future operations will be through the private sale of our securities, either equity or debt.
At June 30, 2017, we had stockholders’ equity of $17,427,536 compared to stockholders’ deficit of $1,865,702 at December 31, 2016.
Off-balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Not required under Regulation S-K for “smaller reporting companies.”
Item 4. Controls and Procedures
(a)
|
Evaluation of Disclosure Controls and Procedures.
|
Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms. Disclosure and control procedures are also designed to ensure that such information is accumulated and communicated to management, including the chief executive officer and principal accounting officer, to allow timely decisions regarding required disclosures.
As of the end of the period covered by this quarterly report, we carried out an evaluation, under the supervision and with the participation of management, including our chief executive officer and principal accounting officer, of the effectiveness of the design and operation of our disclosure controls and procedures. In designing and evaluating the disclosure controls and procedures, management recognizes that there are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their desired control objectives. Additionally, in evaluating and implementing possible controls and procedures, management is required to apply its reasonable judgment. Based on the evaluation described above, management, including our principal executive officer and principal accounting officer, has concluded that, as of June 30, 2017, our disclosure controls and procedures were not effective.
(b)
|
Changes in Internal Control Over Financial Reporting.
|
Management has evaluated whether any change in our internal control over financial reporting occurred during the second quarter of fiscal 2017. Based on its evaluation, management, including the chief executive officer and principal accounting officer, has concluded that there has been no change in our internal control over financial reporting during the second quarter of fiscal 2017 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II — OTHER INFORMATION
Item 1. Legal Proceedings
There are no material pending legal proceedings to which we are a party or to which any of our property is subject and, to the best of our knowledge, no such actions against us are contemplated or threatened.
Item 1A. Risk Factors
Not required under Regulation S-K for “smaller reporting companies.”
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
In the second quarter of 2017, we completed a purchase of 18.72% ownership stake in Rokk3r Labs LLC. Specifically, on April 30, 2017, the Company purchased a minority non-consolidating interest in Rokk3r Labs, LLC., specifically an aggregate of 18.72% of the Member Interests of Rokk3r Labs, LLC. for a purchase price of $1,000,000 (provided at the direction of an entity controlled by Una Taylor for the benefit of the Company) and the issuance of 9,677,208 shares of Company common stock
On April 12, 2017, the Company issued One Million (1,000,000) shares of Series A Preferred Stock to the Company’s current control shareholder in consideration for services rendered.
On April 28, 2017, as consideration for services, for contractual obligations, or the conversion of convertible debentures, an aggregate of 37,261,394 shares of the Company common stock were issued to individuals and entities (including 9,710,295 to our Chief Executive Officer, Una Taylor and 9,677,208 shares to Rokk3r Labs, LLC, in conjunction with the transaction of April 30, 2017 described above, in exchange for 287,067.45 membership units increasing the Company’s minority, non-consolidating investment interest in Rokk3r Labs, LLC to 18.72%).
On June 30, 2017, as consideration for shares of Protect Pharmaceutical Corporation, 3,000,000 shares of our common stock were issued to Protect Pharmaceutical Corporation.
The offer and sale of the securities above were effected in reliance on the exemptions for sales of securities not involving a public offering, as set forth in Rule 506 promulgated under the Securities Act of 1933, as amended (the “Securities Act”) and in Section 4(2) and Section 4(6) of the Securities Act and/or Rule 506 of Regulation D.
Item 3. Defaults Upon Senior Securities
There were no defaults upon senior securities during the period ended June 30, 2017.
Item 4. Mine Safety Disclosures
This Item is not applicable.
Item 5. Other Information
On August 17, 2017, the Board of Directors appointed Una Taylor, the Company Chief Executive Officer, as the Company’s Chief Financial (Accounting) Officer.
Item 6. Exhibits
Exhibit No.
|
|
Exhibit Name
|
|
|
|
2.1(1)
|
|
Patent Acquisition Agreement
|
2.2(1)
|
|
Patent Portfolio
|
3.1(1)
|
|
Articles of Incorporation
|
3.2(1)
|
|
Certificate of Amendment - Capitalization Change
|
3.3(1)
|
|
Certificate of Amendment - Name Change 2006
|
3.4(1)
|
|
Certificate of Amendment - Name Change 2010
|
3.5(2)
3.6(1)
|
|
Certificate of Amendment – Series A Preferred Stock
By-Laws
|
4.1(1)
|
|
Instrument defining rights of holders – Specimen Stock Certificate
|
4.1(2)
|
|
2017 Omnibus Equity Compensation Plan
|
10.1(3)
|
|
Membership Unit Purchase Agreement between Eight Dragons Company and Rocck3r Labs, LLC, dated April 30, 2017.
|
10.2(4)
|
|
Agreement and Plan Of Merger And Reorganization between Eight Dragons Company and Park Roads Solutions, Inc., dated June 1, 2017.
|
14.1(2)
|
|
Financial Code of Ethics
|
31.1
|
|
Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
31.2
|
|
Certification of Principal Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
32.1
|
|
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
32.2
|
|
Certification of Principal Accounting Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
101 INS |
|
XBRL Instance Document |
101 SCH |
|
XBRL Taxonomy Extension Schema Document |
101 CAL |
|
XBRL Taxonomy Calculation Linkbase Document |
101 DEF |
|
XBRL Taxonomy Extension Definition Linkbase Document |
101 LAB |
|
XBRL Taxonomy Labels Linkbase Document |
101 PRE |
|
XBRL Taxonomy Presentation Linkbase Document |
(1) Incorporated by reference to the Company registration statement on Form 10 filed with the SEC on June 8, 2010.
(2) Incorporated by reference to the Company Current Report on Form 8-K filed with the SEC on April 24, 2017.
(3 Incorporated by reference to the Company Current Report on Form 8-K filed with the SEC on May 16, 2017.
(4) Incorporated by reference to the Company Current Report on Form 8-K filed with the SEC on June 7, 2017
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Eight Dragons Company
|
|
|
|
Date: August 21, 2017
|
By:
|
/s/ Una Taylor
|
|
|
|
Una Taylor
|
|
|
Chief Executive Officer
|